Real-time enrollment status for this solid tumor clinical trial
Current Status
Recruiting
Checked: August 27, 2026 at 1:07 PM UTC
| NCT Number | NCT04516447 |
| Recruiting Status | Recruiting |
| Condition | Solid Tumor |
| Phase | PHASE1 |
| Target Enrollment | 172 participants |
| Active Locations | 8 sites in the US |
| Sponsor | K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc |
| Last Updated on CT.gov | April 7, 2026 (Apr 7, 2026) |
As of August 27, 2026: Clinical trial NCT04516447 is currently recruiting participants. This phase1 study for solid tumor is actively seeking new participants at 8 locations across the United States. The study is sponsored by K-Group, Beta, Inc., a wholly owned subsidiary of Zentalis Pharmaceuticals, Inc. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT04516447 is actively recruiting participants as of August 27, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT04516447 was last updated Apr 7, 2026 (April 7, 2026). HelloStudys verifies this status automatically.